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Socioeconomic  status does not affect FEV1 in children with cystic 
fibrosis 
T. Fanaon 1, K. Giles 2, G. Colmett 1,J. Legg 1 
iPaediatric Regional CF Centre, Southarr~ton U iversity Hospitals NHS Trust, UK, 
2South&West Cystic Fibrosis Database, Bath, UK 
Health inequalities according to sc~ioeconomic status (SES) are well described, i A 
US study has reported a significant reduction ha percentage predicted FEV1 ha 
cystic fibrosis (CF) patients receiving Medicaid compared to those who don't7 ha 
the UK, decreased survival has been found ha CF patients of lower social class.s 
The South&West CF database holds information  857 CF patients from the south 
and west of England since 1995. Using the English Index of Multiple Deprivation 
(IMI) 2CO4), we analyzed ata from the database by correlational nalysis to look 
for an association between percentage predicted FEV 1 and SES ha 7 & 10 year olds. 
We also compared FEV1 of patients ha the upper and lower quar tiles of IMD score. 
When cot3cected for sex and pancreatic status, we found no significant difference ha 
FEV1 at either age according to the IMD 2004 score, consistent with findings ha 
older patients by investigators from Bristol, UKJ  
We postulate that equality of access to healthcare provided by the National Health 
Service and Social Services support, contributes to the comparability of lung 
function amongst children with CF ha our region, irrespective of SES. Further 
nationwide analysis of FEV1 across all age groups is indicated to confirm these 
findings and to examine at what stage (if any) differences according to SES become 
significant 
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Clinical management of cystic fibrosis (CF) between 1996 and 2003 in 
a French adult CF care center 
S. Touzet i, S. B ourdy i, S. Fr an~ois 2, G. Bellon ~, R. Nove Josserand ~,C. Colin i, I. 
Durieu 2
IDIM, Hospices Civils de Lyon, France, 2Service de Mddecine Interne, CHLS, Lyon, 
Fratwe, SSetvice de Pddiatrie-Pneumologie, H3pitaI Debrousse, Lyon, Fratwe 
Objective: To describe the evolution of clinical practice patterns in the adult CF 
care center of Lyon between 1996 and 2CO3, before and one year after the 
implementation of national guidelines in 2002 which recommended at least 
quarterly systematic visits in center. 
Methods: Descriptive analysis of 175 of the adults followed up between 1996 mad 
2CO3. The data, including spirometry, microbiological tests and antibiotic therapy, 
have been collected r trospectively from the patient's record for every visit and 
hospitalization hathe CF center from 1996 to 2003. 
Results: The average age at the time of diagnosis was 6.9+11.6 year old. 49.7% of 
the patients had a diagnosis suggested by respiratory problems. 69.1% of patients 
had cbronic colonization with Pseudomonas aeruginosa. The annual average 
number of routine visits for each patient was constant: 4.3+3.1 in 1996, 4.2+3.0 in 
2CO3 (no significant difference). The average number of visits in emergency 
increased significantly: 0.5+1.1 ha 1996, 1.0+1.6 in 2CO3 (p<0.01). The annual 
frequency of the respkatory tests increased significantly from 2.5+1.8 in 1996 to 
3.8+2.5 in 2CO3 (p< l(M) but the microbiological tests were stable between 1996 and 
2CO3 (respectively 3.5+3.0 and 4.1+3.0). The average manual number of antibiotic 
treatments per patient was 2.1+2.2 in 1996 and 2.5+2.3 ha 2CO3 (no significant 
difference). 
Conclusion: These results show that the practice patterns in the French CF center 
of Lyon progressed between 1996 and 2CO3. This study is planned to go on until 
2CO7 to show an improvement in clinical practice as well as the clinical evolution 
of the patients. 
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Projection of lung transplantation for cystic fibrosis needs in France 
from 2001 to 2010 
G. Bellis i, E. Le Roux i'~, Y. Chalem 3, A. parant i, S. Ravilly 2
llnstitut National des Etudes Ddmographiques, Paris, France, 21/~incr  la 
Mucoviscidose, Paris, France, SEtabIissement fizmfais des Gr eff es, Paris, France 
Aims: Lung transplantation has become an option for patients with cystic fibrosis 
and end stage lung disease since 1988 ha France. Using data base of the French 
Registl3, (ONM) projection for transplantable patients have been calculated in order 
to estimate the needs ha the future for lung transplantation in CF, and furthermore 
to contribute to a broader consideration  the necessary adequacy between patients 
needs and public health offers. 
Methods: We used FEV1 (distributed in 10 classes), to indicate respiratory 
function. FEV1 below 30% of theorical value was considered to be the criteria for 
registration on the waiting list. Patients ha whom FEV1 was could observe tbree 
situations: entry, exit tbrough transplantation or death, continuous presence. 
Regarding these situations flaree probabilities have been calculated: mean entl3, 
probability depending on the FEV1, mean exit probability depending on the FEV1, 
mean annual probability to change class. These probabilities have been applied to 
the population known the 3Y t December 2001, from 2CO2 to 2010. 
Resulrs: in 2CO1, 217 CF patients had FEV below 30%. According to our selection 
criteria, we can consider that this represents the number of patients eligible for lung 
transplantation. After 2CO1, the projection of the transplantable population would be 
as follows: 249 in 2CO6 and 313 ha 2010. 
Conclusions: If treatment options and time on the waiting list are unchanged, lung 
transplantation for cystic fibrosis needs are significantly going to increase in the 
short term ha France. 
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Cystic Fibrosis in Adulthood: data from the Italian registry 
A. B ossii, p. Piccinini i, R. Padoan ~, Assemblea dei Direttori dei Centri per la Fibr osi 
Cistica 
llstituto di Statistica Medica e Biometria Univemit2, degli Studi di M lano, 2Centro 
di Supporto per la Fibrosi Cistica, A.O. Spedali CiviIi di Brescia 
Aims: In Italy about half of patPnts with Cystic Flbr c~is(CF) aI~ adults The aim of this study b to 
des~ibe their clinical fe atuI es 
MeNod~: The analysis was catsP d out on all patptits aged 18 yeats or mole recoi ded in the CF Italian 
Regbtry (CFIR) up to the yeat 2001 Ehe expected number of adult patients (AP) in the eat futut~ 
was estimated with linear models as well as with actuatial techniques S xvNal data were fitted with 
the Kaplan MePr model 
/~ eggltz : Accoi ding to he CFIR summary data, there were 1960 indNiduals with CF >1 Bye at old Of 
these, 337 were diagn¢~ed in the tt adulthood; 1640 were alive in 2001 (pt evab nee ofAP: 43%) Table 
1 summatises the demo~,I aphic data and the reason for the initial sweat test DNA of 1661 AP was 
analysed %r CFI"R mutations: 35% of CF pts diagnosed >18yts pt~se nted a mild genotype SmvNal 
at 30 yeats was 090 (95%IC: 086 094) among patients with mild genotyp~ versus 078 (074 082) 
among patients with sevet~ genotyp~ A total of 159 patptits wet~ candidate to tr ans#antation: among 
these 102 wet~ tratisplanted (83 bi pulmonaty), and 31 died befoie satgery 95/102 patients wet~ 
transplanted after 18 yeats of age (mean 26 yrs) 
Conel~ion~: In AR late diagnosis is associated with less pan~eatic itisufficiency, and higher 
ptevalence of mild CFTR mutations In the next yeats adult CF population will account for mor~ than 
50% of Italian CF patients 
Table 1 
Age on 311201 Age at death 
Gender mean max >4O7/ mean rain max 
M 880 P74 590 4% 163 257 181 484 
F 760 280 647 6% 157 ?49 181 470 
Age at diagnosis 
<ly 1 17y >lSy 
Reason foi sweat test (n 577) (n 1046) (n 337) 
Symptoms 671% 916% 904% 
P¢~itive neonatal s~eening 184% 09% 
Meconium ileus 107% 25% 
P¢~itive family hbtoty 39% 50% 9 6% 
DNA analysis: delF508 545% 477% 343% 
Pan~eatic insu ftlciency 936 753 35 3 
